Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1651 1657 1682 1792
This examiner grants 53% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18573419 | RECOMBINANT MICROORGANISM IN WHICH EXPRESSION OF NADH:QUINONE OXIDOREDUCTASE IS CONTROLLED, AND METHOD FOR PRODUCING O-PHOSPHOSERINE, CYSTEINE, AND DERIVATIVE THEREOF BY USING SAME | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 17742035 | PRODUCTION METHOD FOR LIPID PARTICLES IN LIQUID AND METHOD FOR CULTURING MICROORGANISMS | Final Rejection | KANEKA CORPORATION |
| 18516616 | VARIANTS OF A DNA POLYMERASE OF THE POLX FAMILY | Non-Final OA | Centre National De La Recherche Scientifique |
| 18681047 | METHOD FOR PRODUCTION OF AMMONIA, USING INORGANIC NANOPARTICLE-MICROBIAL COMPLEX | Non-Final OA | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 18548730 | XYLOSYLATED STEVIOL GLYCOSIDES AND ENZYMATIC METHODS FOR PRODUCTION | Non-Final OA | CARGILL, INCORPORATED |
| 18250645 | MUTANT PROTEASES AND USES THEREOF | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18110973 | METHOD FOR PRODUCING ORGANIC SUBSTANCE | Final Rejection | SEKISUI CHEMICAL CO., LTD. |
| 17570104 | FUSION PROTEIN NANODISK COMPOSITIONS AND METHODS OF TREATMENT | Final Rejection | The Brigham and Women's Hospital, Inc. |
| 17641586 | BIOFILM TRANSFORMATION | Non-Final OA | Oxford University Innovation Limited |
| 17908925 | COPROCOCCUS BACTERIA FOR USE IN THE TREATMENT OF METABOLIC SYNDROME AND INFLAMMATORY BOWEL DISEASES | Non-Final OA | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) |
| 18277398 | METHOD FOR PRODUCING A HYDROXYTYROSOL | Non-Final OA | Wacker Chemie AG |
| 18392498 | Reducing or Inhibiting Ocular Damage by Hyaluronidase Administration | Non-Final OA | Med Progress, LLC |
| 17799190 | SPRAY FREEZE DRYING OF STRICT ANAEROBIC BACTERIA | Final Rejection | Chr. Hansen A/S |
| 17594994 | METHODS FOR THE FRACTIONATION OF PROTEINS | Final Rejection | THE UNIVERSITY OF SYDNEY |
| 18551182 | MODIFIED HOST CELLS FOR HIGH EFFICIENCY PRODUCTION OF VANILLIN | Non-Final OA | AMYRIS , INC. |
| 18575597 | ENHANCED EXPRESSION OF AN AROMATIC AMINO ACID DECARBOXYLASE (AADC) IN THE SUBSTANTIA NIGRA FOR THE TREATMENT OF PARKINSON'S DISEASE | Non-Final OA | Comell University |
| 18398273 | RECOMBINANT PROTEIN CAPABLE OF RESISTING MULTIPLE SCLEROSIS AND PREPARATION METHOD AND APPLICATION THEREOF | Non-Final OA | INSTITUTE OF ZOOLOGY, GUANGDONG ACADEMY OF SCIENCES |
| 17769452 | METHOD FOR EVALUATING DRUG TOXICITY | Non-Final OA | Takeda Pharmaceutical Company Limited |
| 18569824 | COMPOSITIONS AND METHODS FOR MICROBIAL TREATMENT OF SKIN DISORDERS | Non-Final OA | IFF US Holding, LLC |
| 17311262 | COMPOSITIONS FOR STABILIZING BACTERIA AND USES THEREOF | Final Rejection | Seres Therapeutics, Inc. |
| 17603978 | CATALYTICALLY INACTIVE BOTULINUM NEUROTOXIN-LIKE TOXINS AND USES THEREOF | Non-Final OA | Children's Medical Center Corporation |
| 17294587 | MICROFLUIDIC IN VITRO MODEL FOR ELUCIDATING THE MOLECULAR EFFECTS OF SIMULATED DIETARY REGIMENS ON GUT MICROBIOTA AND HOST CELLS | Non-Final OA | Universite Du Luxembourg |
| 17610249 | POLYPEPTIDES FOR TREATMENT OF BACTERIAL INFECTIONS | Non-Final OA | CC Biotech Ltd. |
| 18010092 | ENGINEERED MAD7 DIRECTED ENDONUCLEASE | Final Rejection | BIO-TECHNE CORPORATION |
| 17760007 | TAFA4 POLYPEPTIDE OR POLYNUCLEOTIDE FOR TREATING INFLAMMATORY DISEASE | Final Rejection | UNIVERSITÉ D'AIX MARSEILLE |
| 17767791 | MULTI-DOMAIN PROTEIN VACCINE | Non-Final OA | DIONIS THERAPEUTICS, INC. |
| 17767210 | METHOD FOR COVALENT IMMOBILIZATION OF MOLECULAR COMPOUNDS | Non-Final OA | THE UNIVERSITY OF NEWCASTLE |
| 17620604 | LACTOBACILLUS COMPOSITIONS AND USES THEREOF | Final Rejection | Probi AB |
| 17611090 | METHODS OF PROCESSING A FAVA BEAN COMPOSITION | Non-Final OA | THE GREEN DAIRY SWEDEN HOLDING AKTIEBOLAG |
| 17601963 | RNA SITE-DIRECTED EDITING USING ARTIFICIALLY CONSTRUCTED RNA EDITING ENZYMES AND RELATED USES | Non-Final OA | SHANGHAI INSTITUTE OF NUTRITION AND HEALTH, CHINESE ACADEMY OF SCIENCES |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy